Host

Carlos Minnutti, Group Leader at Champalimaud Research

Venue

Seminar room

Host

Francesco Costantino, PhD Student, Champalimaud Research

Venue

Seminar room

The laureates of the 2024 António Champalimaud Vision Award are researchers Margaret Livingstone, Nancy Kanwisher, Doris Tsao (from the United States) and Winrich Freiwald (Germany) for their innovative contributions to understanding the neural mechanisms underlying facial recognition.  
 
The collective work carried out by these researchers has led to significant advances in the field of visual neuroscience, demonstrating how the brain processes and recognises faces, a fundamental aspect of social interaction and human cognition.
 

The ERC Starting Grant is one of Europe’s most prestigious and competitive research awards, designed to support promising early-career researchers who have the potential to become leaders in their fields. Ianuş will receive €2M over the next five years to develop her research project at King’s College London, where she recently joined as a Lecturer in Healthcare Engineering.

Host

Carlos Minutti, Principal Investigator, Champalimaud Research 

Venue

Seminar room

How do we learn to make sense of our environment? Over time, our brain builds a hierarchy of knowledge, with higher-order concepts linked to the lower-order features that comprise them. For instance, we learn that cabinets contain drawers and that Dalmatian dogs have black-and-white patches, and not vice versa. This interconnected framework shapes our expectations and perception of the world, allowing us to identify what we see based on context and experience.

Using zebrafish “Avatars”, an animal model developed by the Cancer Development and Innate Immune Evasion lab at the Champalimaud Foundation (CF), led by Rita Fior, Mayra Martínez-López – a former PhD student at the lab now working at the Universidad de las Américas in Quito, Ecuador – and colleagues studied the initial steps of the Bacillus Calmette-Guérin (BCG) vaccine’s action on bladder cancer cells.

Co-organised by Fundación CIEN, Fundación Reina Sofía, and the Champalimaud Foundation, this scientific congress aims to bring advances in research in the fight against Alzheimer's and other neurodegenerative diseases to the public, and above all, to raise awareness to advance the search for global solutions and responses due to their social consequences.

Experts from two international nuclear medicine societies (EANM and SNMMI) have joined those from important societies of various other medical specialities involved in the care of breast cancer patients – including oncology, surgery, radio-oncology and breast imaging – to draw up a set of recommendations, based on scientific evidence, on the correct utilisation, in breast cancer, of a medical imaging exam. The exam in question has been used for several years and involves radioactive substances, in this case a glucose analogue called fluorodeoxyglucose (FDG).